Table 1.
Malarial control group 1 (n = 998) |
Severe malaria case group 1 (n = 684) |
Control group 2 (n = 1,706) |
Severe malaria case group 2 (n = 731) |
Combined |
|||||||
n | Frequency | n | Frequency | P value | n | Frequency | n | Frequency | P value | P value | |
II | 475 | 0.476 | 345 | 0.504 | 875 | 0.513 | 391 | 0.534 | |||
TT | 87 | 0.087 | 31 | 0.045 | 4.1 × 10−3*† | 125 | 0.073 | 34 | 0.047 | 0.048* | |
IT | 436 | 0.436 | 308 | 0.450 | 706 | 0.414 | 306 | 0.419 | |||
TT | 87 | 0.087 | 31 | 0.0453 | 1.0 × 10−3‡ | 125 | 0.073 | 34 | 0.047 | 0.019‡ | 7.1 × 10−5§ |
IT and II | 911 | 0.913 | 653 | 0.955 | OR = 0.50 | 1,581 | 0.927 | 696 | 0.953 | OR = 0.62 | OR = 0.56 |
(0.33–0.76) | (0.42–0.91) | (0.42–0.74) |
II denotes individuals homozygous for FcγRIIbI232, TT denotes individuals homozygous for FcγRIIbT232, and IT denotes heterozygotes.
*P value was calculated by χ2 test using 2 × 3 contingency table (df = 2).
†Genotype was not associated with specific features of severe malaria, including hematocrit, parasitemia, conscious level, or respiratory symptoms (multiple logistic regression) (Table S8).
‡P value and OR calculated by χ2 test using 2 × 2 contingency table (df = 1). Numbers in parentheses refer to 95% confidence intervals.
§Combined P value from meta-analysis of the two cohorts using StatsDirect software.